Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets ...

Buprenorphine (as HCl) 2mg, 8mg; sublingual tabs. Dissolve under tongue; do not swallow tabs. Avoid food or drinks until tab dissolves. Rinse teeth/gums with water after tab dissolves, and swallow.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Zolpidem tartrate 1.75mg, 3.5mg. Zolpidem interacts with gamma-aminobutyric acid-benzodiazepine (GABA-BZ) receptor complex and shares some of the pharmacological properties of benzodiazepines.

NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets ...

China’s National Medical Products Administration (NMPA) granted new approvals to several Chinese biopharmaceuticals this week, including expanding indications of four different cancer drugs and ...

Simcere Pharmaceutical Group Limited (HK:2096) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with ...

Troikaa Pharma announced that it has launched its Zolpidem Sublingual Spray 3.85% w/v, for the treatment of short term insomnia under the brand name of Zolswift-SL. Developed through extensive ...

BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...

The reputable scientific journal, The Lancet Regional Health – Europe, has published robust results from ALK’s house dust mite sublingual allergy immunotherapy tablet (SLIT-tablet) phase 3 children ...